The RTOG 98-11 trial rand omized patients with anal cancer to stand ard concurrent 5-fluorouracil and mitomycin C versus induction cisplatin and 5-fluorouracil followed by radiation (55–59 Gy) with concurrent cisplatin and 5-fluorouracil. What were the results of the long-term updated analysis?